Search
ut-irb-no-11607-896-body-fat-clinical-trial-022811-final.pdf
https://labs.utsouthwestern.edu/sites/default/files/2022-07/ut-irb-no-11607-896-body-fat-clinical-trial-022811-final.pdf
© U T So ut hw es te rn M ed ic al C en te r, 20 11 . M KT 8 96 _0 3 Qualified participants must be: • Between age 18–70 years • South Asian or European Americans • Male and Female • Able to attend two visits • �Persons taking medications for diabetes, heart disease or chronic health issues may not qualify For more information 214.648.9014 Are you interested in research on body fat?
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
https://labs.utsouthwestern.edu/sites/default/files/2022-08/102_Wang_Nat%20MaterRed.pdf
ARTICLES PUBLISHED ONLINE: 8 DECEMBER 2013 | DOI: 10.1038/NMAT3819 A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals Yiguang Wang1, Kejin Zhou1, Gang Huang1, Christopher Hensley2, Xiaonan Huang1, Xinpeng Ma1, Tian Zhao1, Baran D. Sumer3, Ralph J. DeBerardinis2 and Jinming Gao1* Stimuli-responsive nanomaterials are increasingly important in a variety of applications such as biosensing, molecular imaging, drug
Endothelial Mechanisms Contributing to Type 2 Diabetes Development | Shaul / Mineo Lab | UT Southwestern, Dallas, Texas
https://labs.utsouthwestern.edu/shaul-mineo-lab/research/endothelial-mechanisms-contributing-type-2-diabetes-development
Endothelial Mechanisms Contributing to Type 2 Diabetes Development
A transistor-like pH nanoprobe for tumour detection and image-guided surgery
https://labs.utsouthwestern.edu/sites/default/files/2022-08/115_Zhao_NatBME.pdf
NATURE BIOMEDICAL ENGINEERING 1, 0006 (2016) | DOI: 10.1038/s41551-016-0006 | www.nature.com/natbiomedeng 1 ARTICLES PUBLISHED: 19 DECEMBER 2016 | VOLUME: 1 | ARTICLE NUMBER: 0006 A transistor-like pH nanoprobe for tumour detection and image-guided surgery Tian Zhao1†, Gang Huang1, Yang Li1, Shunchun Yang1, Saleh Ramezani2, Zhiqiang Lin1, Yiguang Wang1, Xinpeng Ma1, Zhiqun Zeng1, Min Luo1, Esther de Boer3, Xian-Jin Xie4, Joel Thibodeaux5, Rolf A. Brekken6, Xiankai Sun2, Baran D. Sumer7
People | Minassian Lab | UT Southwestern, Dallas, Texas
https://labs.utsouthwestern.edu/minassian-lab/people
Meet the Minassian Lab team.
Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery
https://labs.utsouthwestern.edu/sites/default/files/2022-08/127_Voskuil_NComm_ClinicalTrial.pdf
ARTICLE Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery F. J. Voskuil 1,13, P. J. Steinkamp 2,13, T. Zhao3, B. van der Vegt 4, M. Koller2, J. J. Doff4, Y. Jayalakshmi3, J. P. Hartung5, J. Gao 6,7, B. D. Sumer 6✉, M. J. H. Witjes1, G. M. van Dam 2,8✉ & the SHINE study group* Cancer cell metabolism leads to a uniquely acidic microenvironment in solid tumors, but exploiting the labile extracellular pH differences
Personnel | Herz Lab | UT Southwestern, Dallas, Texas
https://labs.utsouthwestern.edu/herz-lab/about-us/personnel
Meet the Herz Lab team
125_Bennett_Theranostics_2020.pdf
https://labs.utsouthwestern.edu/sites/default/files/2022-08/125_Bennett_Theranostics_2020.pdf
Theranostics 2020, Vol. 10, Issue 7 http://www.thno.org 3340 Theranostics 2020; 10(7): 3340-3350. doi: 10.7150/thno.41239 Research Paper Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles Zachary T. Bennett1, Qiang Feng1, Justin A. Bishop2, Gang Huang1, Baran D. Sumer3, and Jinming Gao1,3 1. Department of Pharmacology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 2
Cell Line Repository | Napierala Lab | UT Southwestern, Dallas, Texas
https://labs.utsouthwestern.edu/napierala-lab/cell-line-repository
See the Napierala Lab's research
ind-162493-amendment-2-advertisement-flyer-08-22-2023.pdf
https://labs.utsouthwestern.edu/sites/default/files/2023-09/ind-162493-amendment-2-advertisement-flyer-08-22-2023.pdf
\ PEGSITACIANINE FOR THE SURGICAL DETECTION OF HEAD AND NECK CANCER PURPOSE INCLUSION DESIGN To investigate whether Pegsitacianine a fluorescent nanoparticle can image head and neck cancer and unknown primary head and neck cancer during surgery or biopsy. 1. Adults ≥ 18 years of age 2. Patients with stage 1-4 Head and Neck Squamous Cell Carcinoma (HNSCC) undergoing surgical excision 1. Phase 2 Clinical trial of Pegsitacianine, which is